Efficacy and safety of alogliptin in patients with type 2 diabetes mellitus: A multicentre randomized double-blind placebo-controlled Phase 3 study in mainland China, Taiwan, and Hong Kong (Q40757945)
Jump to navigation
Jump to search
scientific article published on 12 May 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of alogliptin in patients with type 2 diabetes mellitus: A multicentre randomized double-blind placebo-controlled Phase 3 study in mainland China, Taiwan, and Hong Kong |
scientific article published on 12 May 2016 |
Statements
1 reference
Efficacy and safety of alogliptin in patients with type 2 diabetes mellitus: A multicentre randomized double-blind placebo-controlled Phase 3 study in mainland China, Taiwan, and Hong Kong (English)
1 reference
1 reference
Changyu Pan
1 reference
Ping Han
1 reference
Qiuhe Ji
1 reference
Chengjiang Li
1 reference
Juming Lu
1 reference
Jinkui Yang
1 reference
Wenhui Li
1 reference
Jiaoe Zeng
1 reference
An-Tsz Hsieh
1 reference
12 May 2016
1 reference
1 reference
9
1 reference
4
1 reference
386-395
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference